DBL Expression Driven by the Neuron Specific Enolase Promoter Induces Tumor Formation in Transgenic Mice with a P53(±) Genetic Background

• Published in: Biochemical and biophysical research communications 1995-11, Vol.216 (3), p.762-770
• Main Authors: Coluccidamato, G.L., Santelli, G., Dalessio, A., Chiappetta, G., Mineo, A., Manzo, G., Vecchio, G., Defranciscis, V.
• Format: Article
• Language: English
• Subjects: Animals; Base Sequence; Blotting, Northern; Blotting, Southern; Crosses, Genetic; DNA Probes; Gene Expression; Guanine Nucleotide Exchange Factors; Heterozygote; Homozygote; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Molecular Sequence Data; Neoplasms, Experimental - genetics; Phosphopyruvate Hydratase - genetics; Promoter Regions, Genetic; Retroviridae Proteins, Oncogenic - genetics; Tumor Suppressor Protein p53 - deficiency; Tumor Suppressor Protein p53 - genetics; Tumor Suppressor Protein p53 - physiology
• ISSN: 0006-291X; 1090-2104
• DOI: 10.1006/bbrc.1995.2687

The dbl oncogene, generated by the truncation of the amino-terminal portion of the proto-oncogene sequence, encodes a guanine-nucleotide-releasing factor. The transforming activity of this oncogene has never been demonstrated in vivo or in vitro except in the NIH 3T3 mouse fibroblast cell line. The expression of the proto-dbl transcript is confined to tissues and tumors of neuroectodermal derivation. Therefore, to study the transforming activity of the dbl oncogene in vivo. we have generated transgenic mice that express this oncogene in neuroepithelial tissues. Mice carrying the dbl oncogene did not develop a tumor. Successively, to establish whether dbl interacts with the tumor suppressor gene p53 in tumorigenesis, we have used a p53 deficient mouse strain. The results reported here indicate that dbl is capable of causing tumor formation in vivo when its expression is driven in an appropriate cellular and genetic environment.